glp.1 drugs America's Poison Centers As GLP-1 drugs go mainstream,

a Findings are based on post hoc analyses or subgroup-specific reports from RCTs unless otherwise indicated

( 7 ) However, these side effects typically subside over time as the body gets used to the new medication

Matfin G, Van BK, Zimmermann AG, Threlkeld R, Ignaut DA

Introduction Nonalcoholic fatty liver disease (NAFLD) is characterized by the accumulation of fat in the liver, which can progress to nonalcoholic steatohepatitis (NASH), fibrosis, and cirrhosis [1]

The authors suggest this provides evidence that intestinally derived GLP-1 can compensate for the lack of -cell GLP-1

C., Sattar N., Rosenstock J., Ramasundarahettige C., Pratley R., Lopes R